UK Researchers Report New Clues in the Search for Better Medicine Delivery
UK medical research advances as new studies and funding signal progress toward better patient care and NHS impact.
Studies on new and existing drugs and treatments, from early discovery to real-world results.
Targeted MS Therapy Shows Early Promise Without Broad Immune Suppression
Early trial data suggest a targeted multiple sclerosis therapy may retrain immunity without broadly suppressing the immune system.
NHS-Linked Study Finds Digital Support Can Improve TB Treatment Adherence
BMJ study finds patient-centred digital adherence technology improved tuberculosis treatment outcomes in a pragmatic trial.
Nature Medicine Highlights Heart-Failure Therapy Safety Signals in 38,753-Patient Analysis
Nature Medicine reports a 38,753-patient analysis on heart-failure therapy effects on blood pressure, kidney function and potassium.
New Nature Medicine study points to stronger AI support in emergency care
Nature Medicine reports a prospective emergency department AI study, advancing clinical decision support research in medicine.
Nature Medicine reports early promise for AI-assisted emergency care
Nature Medicine reports a pilot AI decision-support tool was safe in emergency care, but clinician use declined over four weeks.
Single-Cell Research Sheds New Light on Why Some CAR-T Therapies Succeed
Single-cell research reveals why some CAR-T therapies work better, offering new clues for more precise cancer treatment.
KRAS-Targeting Drug Shows Early Promise in First Clinical Test
Setidegrasib shows early promise in a first clinical test for KRAS G12D-driven solid tumors.
NICE and MHRA launch faster route to bring new medicines to patients
NICE and MHRA launch a faster approval pathway that could bring new medicines to patients 3 to 6 months sooner.
ASA bans ‘irresponsible’ social media ads for weight-loss drugs by Chequp, SkinnyJab and MedExpress
ASA bans social media ads by Chequp, SkinnyJab and MedExpress for illegally promoting prescription-only weight-loss drugs and exploiting body image insecurities.
